Skip to main content
Clinical Trials/NCT03921801
NCT03921801
Completed
Not Applicable

Improving Plantarflexor Muscle Function to Alleviate Decline in Mobility, Loss of Balance and Detrimental Knee Joint Loading in Older Adults

University of Eastern Finland1 site in 1 country30 target enrollmentApril 13, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis, Knee
Sponsor
University of Eastern Finland
Enrollment
30
Locations
1
Primary Endpoint
Change from baseline in knee joint loading
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study investigates the role of calf muscle function in gait performance, balance and knee joint loading.

Previous studies have linked age-related loss of calf muscle function with impairments in gait performance and balance, and increased loading of the areas of the knee joint that are susceptible to the development of osteoarthritis. In this study, an exercise intervention targeting structural and neural aspects of impaired calf muscle function with ageing is utilized. The intervention lasts 8 weeks and includes either biofeedback training using electromyography to alter muscle activation patterns or a combination of biofeedback training and strength training for the calf muscle to modify calf function during walking. The study will test whether the intervention improves walking speed, reduces the metabolic cost of walking, improves standing balance and reduces knee joint loading.

Registry
clinicaltrials.gov
Start Date
April 13, 2023
End Date
February 28, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lauri Stenroth

Senior Researcher

University of Eastern Finland

Eligibility Criteria

Inclusion Criteria

  • age between 65 and 75

Exclusion Criteria

  • dependent living status
  • not able to walk without an assistive device or for 30 min without stopping
  • diagnosed neurological disease or joint disorder and pain during walking
  • surgery on lower extremities
  • current musculoskeletal injury
  • previous cardiovascular event or symptoms during exercise (acute ECG change, coronary disease, symptomatic arrhythmia, symptomatic coronary stenosis, heart failure, myocarditis, pericarditis, pulmonary embolism, pulmonary infarct, artery bulge or rupture risk)
  • body mass index \<18 or \>35 kg/m2
  • contraindications for magnetic resonance imaging
  • Mini Mental State Examination score of 23 points and lower

Outcomes

Primary Outcomes

Change from baseline in knee joint loading

Time Frame: within 1 weeks after intervention

Change in tibiofemoral compressive loading during walking estimated using musculoskeletal modeling and simulation. Loading is calculated separately for medial and lateral compartments of the tibiofemoral joint.

Secondary Outcomes

  • Change from baseline in muscle strength(within 1 weeks after intervention)
  • Change from baseline in joint moments during walking(within 1 weeks after intervention)
  • Change from baseline in walking speed(within 1 weeks after intervention)
  • Change from baseline in joint powers during walking(within 1 weeks after intervention)
  • Change from baseline in distribution of joint work during walking(within 1 weeks after intervention)
  • Change from baseline in energy cost of walking(within 1 weeks after intervention)
  • Change from baseline in Achilles tendon stiffness(within 1 weeks after intervention)
  • Change from baseline in standing balance(within 1 weeks after intervention)
  • Change from baseline in muscle-tendon function during walking(within 1 weeks after intervention)
  • Change from baseline in soleus to gastrocnemius muscle activation ratio(within 1 weeks after intervention)
  • Change from baseline in gait kinematics(within 1 weeks after intervention)

Study Sites (1)

Loading locations...

Similar Trials